The Latest

THE LATEST Discovery

THE LATEST THINKING

New data shows that humans carry antibodies and even T-cells that target the Cas9 protein at the heart of CRISPR gene editing technology.

Photo by: Seeker - Science. World. Exploration. Seek for yourself.

Credit: Westend61 via Getty Images An early draft of a scientific paper about potential human immunity to the Cas9 protein caused the stock prices of companies developing CRISPR-based therapies to plummet last week as investors questioned whether the controversial genome-editing technology would ever be safe for humans. Matthew Porteus, lead author of the paper and an associate professor...

See article

THE LATEST THINKING

The opinions of THE LATEST’s guest contributors are their own.

Searching for TLT's ...

Video Site Tour

The Latest
The Latest

Subscribe to THE LATEST Newsletter.

The Latest
The Latest

Share this story through...

Separate multiple emails with commas. That's not a valid e-mail.